Skip to main content
Deepak D'Souza, MD, Psychiatry, West Haven, CT, Veterans Affairs Connecticut Healthcare System

DeepakCyrilD'SouzaMD

Psychiatry West Haven, CT

Professor of Psychiatry; Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); Director, Neurobiological Studies Unit, VACHS; Director, VA-CMHC Schizophrenia Research Clinic

Are you Dr. D'Souza?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 34 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    950 Campbell Ave
    Psychiatry Svc 116a, Va Connecticut Healthcare System
    West Haven, CT 06516
    Phone+1 203-932-5711
    Fax+1 203-937-4860
  • Is this information wrong?

Summary

  • Dr. Deepak D'Souza, MD is a board certified psychiatrist in West Haven, Connecticut. He is currently licensed to practice medicine in Connecticut. He is affiliated with Veterans Affairs Connecticut Healthcare System and Hartford Hospital.

Education & Training

  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Psychiatry, 1988 - 1992
  • St. John's Medical College
    St. John's Medical CollegeClass of 1986

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1993 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • California May Require Labels on Pot Products to Warn of Mental Health Risks
    California May Require Labels on Pot Products to Warn of Mental Health RisksJune 17th, 2022
  • There's No Evidence Marijuana Will Treat Your Anxiety or Depression
    There's No Evidence Marijuana Will Treat Your Anxiety or DepressionOctober 28th, 2019
  • Scarce Evidence Backing Cannabinoids for Psych Disorders
    Scarce Evidence Backing Cannabinoids for Psych DisordersOctober 28th, 2019

Grant Support

  • Imaging Brain Cannabinoid Receptors (CB1) In SchizophreniaNational Institute Of Mental Health2012
  • Imaging Brain Cannabinoid Receptors In Cannabis Dependence, Withdrawal And AbstinNational Institute On Drug Abuse2011
  • Cannabidiol Modulation Of ???-9-Thc???S Psychotomimetic Effects In Healthy HumansNational Institute On Drug Abuse2011
  • Imaging Nicotinic Acetylcholine Receptors In SchizophreniaNational Institute On Drug Abuse2009–2011
  • GABA Deficits And Vulnerability To Cannabinoid-Induced PsychosisNational Institute Of Mental Health2009–2010
  • Neurobiology Of Cannabis EffectsNational Institute On Drug Abuse2007–2009
  • Cannabinoids, Neural Synchrony And Information ProcessingNational Institute On Drug Abuse2007–2008
  • Cannabinoid Receptor Function In Alcoholism: Effects Of D-9-ThcNational Institute On Alcohol Abuse And Alcoholism2007–2008
  • Neurobiology Of Cannabis Behavioral EffectsNational Institute On Drug Abuse2001–2003
  • Glycine-Ketamine Interactions In Healthy SubjectsNational Institute Of Mental Health2000–2002
  • Effects In Schizophrenics Versus Healthy Controls.National Institute On Alcohol Abuse And Alcoholism1998–1999

Hospital Affiliations